PCM
ABBV icon

Pentwater Capital Management’s AbbVie ABBV Stock Holding History

Pentwater Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$3.64M – 157
2019
Q2 		$3.64M Buy
+50,000
New +$3.93M 0.04% 98
2014
Q4 		– Sell
-350,000
Closed -$20.2M – 149
2014
Q3 		$20.2M Buy
+350,000
New +$19.4M 0.19% 75

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pentwater Capital Management's ABBV Position: Q1 2020 in Review

Pentwater Capital Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 1,113 shares — an estimated $99K sold.

Pentwater Capital Management first reported a position in ABBV in Q4 2019 and held it in 1 quarter. The position peaked at $99K in Q4 2019. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • Pentwater Capital Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 1,113 AbbVie shares in Q1 2020, an estimated $99K.
  • Pentwater Capital Management first reported a position in AbbVie in Q4 2019 and held it in 1 quarter.
  • Pentwater Capital Management's AbbVie position peaked at $99K in Q4 2019.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on Pentwater Capital Management's 13F filing for Q1 2020, filed 15 May 2020.